Medtronic and Fitbit are teaming-up to integrate health and activity tracking for patients living with diabetes and their physicians and care teams.
As a result of this partnership, the iPro2 myLog mobile app to allow patients living with type 2 diabetes to see their glucose levels and physical activity data in one streamlined application. The integration will bring together Medtronic’s medical technology with the convenience of automatic activity tracking from Fitbit to provide meaningful insights into how exercise impacts glucose levels for more effective diabetes care management.
“By creating a connection between physical activity and glucose levels, our iPro2 myLog mobile app solution provides new tools and insights, so that physicians can optimize therapy and patients can better understand how to manage their diabetes,” Laura Stoltenberg, vice president and general manager of Non-Intensive Diabetes Therapies at Medtronic, said in a statement. “By helping people with diabetes implement lasting lifestyle changes, this partnership underscores our commitment to transforming diabetes care, together, for greater freedom and better health.”
For people living with type 2 diabetes, understanding how exercise affects glucose levels is a critical element to proper glucose management and long-term health. Many patients are already manually tracking and recording their physical activity, but with the iPro2 myLog app they will be able to that automatically, and combine Fitbit data with Medtronic’s iPro2 professional Continuous Glucose Monitor (CGM) system. MyLog will also simplify the sharing of information with a patient’s healthcare team, facilitating productive discussions about care and the benefits of exercise on diabetes management.
“By partnering with Medtronic, we are able to bring the power of Fitbit’s automatic activity tracking together with continuous glucose monitoring, allowing patients and providers to have a more informed conversation,” Adam Pellegrini, vice president of Digital Health for Fitbit, said in a statement.